Genprex GNPX Insider Ownership

NASDAQ GNPX
$2.56 -0.36 (-12.33%)
At close: Oct 1, 2026 · 4:00 PM EDT

Insider Holdings by Owner

77.80K Shares

Insider Ownership Statistics

as of 30 Sep, 2026
Insider Ownership
17.18%
■0% pp QoQ
Shares Held by Insiders
81.28K
filed for Sep 2026
■0.00% QoQ
Shares Outstanding
473.16K
473,162 shares
Direct Holdings
77.80K
Indirect: 3.48K
Net Shares Traded (QoQ)
0
no net change in Sep 2026
Insiders Holding Shares
8
with Form 4 holdings on file

Shares Owned by Insiders

Shares held % of outstanding
Latest —
Average ownership —
Peak ownership —

Shares Purchased/Sold by Insiders

Bought Sold
Latest quarter —
Net over range —
Buying quarters —

Insider Ownership Summary

Quarter ending 30 Sep, 2026

As of September 29, 2026, the three largest insider holders of GNPX are Catherine M Vaczy (Evp Gc Chief Strategy Officer, 44.28K shares), Hermant Kumar (Chief Mfgr Tech Officer, 33.42K shares), John Rodney Varner (Chairman, President And Ceo, 3.48K shares).

Form 4 Holdings

Insiders Holding GNPX

Insiders 8
Shares held 77.80K
Of outstanding 16.44%
# Insider Position Direct Indirect Total Share of Insiders Last Filed
1 Catherine M Vaczy Evp Gc Chief Strategy Officer 44,283 0 44,283 56.9% 24 Apr, 2023
2 Hermant Kumar Chief Mfgr Tech Officer 33,421 0 33,421 43.0% 22 Feb, 2023
3 John Rodney Varner Chairman, President And Ceo 88 0 88 0.1% 21 Feb, 2024
4 Ryan M. Confer President, Ceo And Cfo 6 0 6 0.0% 27 Feb, 2026
5 Mark Stanley Berger Chief Medical Officer 3 0 3 0.0% 27 Feb, 2026
6 Toscano Jose Antonio Moreno Director 1 0 1 0.0% 23 Dec, 2025
7 William R Jr. Wilson Director 1 0 1 0.0% 23 Dec, 2025
8 Brent M Longnecker Director 1 0 1 0.0% 15 Apr, 2026

Each row is that insider’s most recently reported position, from Form 4 filings over the last 60 months — which is why this total does not tie to the quarterly series above, where a quarter counts only the insiders who filed in it. Shares held through a fund or institutional portfolio are counted on the institutional ownership page instead.

Form 4 Filings

86 Insider Transactions

Source SEC Form 4
Latest quarter Sep 2026
Download Data
Date Insider Position Transaction Shares Price Value Shares Held After Ownership
14 Apr, 2026 Brent M Longnecker Director Disposed S 8 $8,096.71 $64.77K 1 Direct
14 Apr, 2026 Brent M Longnecker Director Disposed S 10 $8,096.71 $80.97K 0 Indirect
27 Feb, 2026 Ryan M. Confer President, Ceo And Cfo Disposed F 9,330 $13,165.38 $122.83Mn 6 Direct
27 Feb, 2026 Mark Stanley Berger Chief Medical Officer Disposed F 7,168 $13,165.38 $94.37Mn 3 Direct
22 Dec, 2025 Brent M Longnecker Director Acquired A 9,000 $0.00 $0 1 Direct
22 Dec, 2025 Toscano Jose Antonio Moreno Director Acquired A 9,000 $0.00 $0 1 Direct
22 Dec, 2025 Mark Stanley Berger Chief Medical Officer Acquired A 28,500 $0.00 $0 4 Direct
22 Dec, 2025 William R Jr. Wilson Director Acquired A 9,000 $0.00 $0 1 Direct
22 Dec, 2025 Ryan M. Confer President, Ceo And Cfo Acquired A 45,000 $0.00 $0 7 Direct
30 Jun, 2025 Mark Stanley Berger Chief Medical Officer Disposed F 4,500 $68.19 $306.86K 60 Direct
30 Jun, 2025 Ryan M. Confer President, Ceo And Cfo Disposed F 5,775 $68.19 $393.80K 110 Direct
18 Feb, 2025 Mark Stanley Berger Chief Medical Officer Disposed F 585 $122.68 $71.77K 75 Direct
18 Feb, 2025 Ryan M. Confer President, Ceo And Cfo Disposed F 395 $122.68 $48.46K 129 Direct
05 Dec, 2024 Toscano Jose Antonio Moreno Director Acquired A 4,750 $0.00 $0 26 Direct
05 Dec, 2024 William R Jr. Wilson Director Acquired A 4,750 $0.00 $0 26 Direct
05 Dec, 2024 Ryan M. Confer President, Ceo And Cfo Acquired A 29,375 $0.00 $0 131 Direct
05 Dec, 2024 Mark Stanley Berger Chief Medical Officer Acquired A 18,250 $0.00 $0 77 Direct
05 Dec, 2024 Brent M Longnecker Director Acquired A 4,750 $0.00 $0 27 Direct
18 Feb, 2024 Mark Stanley Berger Chief Medical Officer Disposed F 1,319 $1,316.54 $1.74Mn 16 Direct
18 Feb, 2024 John Rodney Varner Chairman, President And Ceo Disposed F 2,642 $1,316.54 $3.48Mn 88 Direct